LCZ696 vs enalapril in chronic heart failure

• Research type

  Research Study

• Full title

  A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure and reduced ejection fraction (CLCZ696B2314)

• IRAS ID

  34015

• Sponsor organisation

  Novartis Pharma Services AG

• Eudract number

  2009-015834-31

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• Research summary

  N/A

• REC name

  East Midlands - Leicester Central Research Ethics Committee

• REC reference

  09/H0406/110

• Date of REC Opinion

  18 Nov 2009

• REC opinion

  Favourable Opinion